AQST

Aquestive Therapeutics Stock Price

3.41
-0.10 (-2.85%)
Upgrade to Real-Time
Afterhours (Closed)
3.41

Low
3.38

52 Week Range

High
9.465

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Aquestive Therapeutics Inc AQST NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.10 -2.85% 3.41 20:00:00
Open Price Low Price High Price Close Price Prev Close
3.52 3.38 3.67 3.42 3.51
Bid Price Ask Price Spread News
3.40 3.46 0.06 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
4,710 519,582 $ 3.52 $ 1,827,436 713,484 3.38 - 9.465
Last Trade Time Type Quantity Stock Price Currency
19:28:50 2 $ 3.46 USD

Aquestive Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 123.49M 36.21M 21.08M $ 45.85M $ - -1.66 -2.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% -1.11M 6.10%

more financials information »

Aquestive Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AQST Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week4.1154.253.383.76660,117-0.705-17.13%
1 Month4.804.853.384.08573,545-1.39-28.96%
3 Months6.266.623.384.79827,008-2.85-45.53%
6 Months5.648.063.385.50816,977-2.23-39.54%
1 Year4.419.4653.385.83934,489-1.00-22.68%
3 Years15.0520.69611.415.97553,366-11.64-77.34%
5 Years15.0520.69611.415.97553,366-11.64-77.34%

Aquestive Therapeutics Description

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. The product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS). Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.


Your Recent History
NASDAQ
AQST
Aquestive ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.